Prodigy Study Duration Of Dual Antiplatelet Therapy Under Review

Prodigy Study Duration Of Dual Antiplatelet Therapy Under Review. Aug 01, 2012 · prodigy study: What was the duration of the prodigy study?

Emir YONAS | Doctor of Medicine | Universitas YARSI, Jakarta
Emir YONAS | Doctor of Medicine | Universitas YARSI, Jakarta from www.researchgate.net
Aug 17, 2020 · watanabe h, domei t, morimoto t, et al. A report of the american college of cardiology/american heart association task force on clinical practice guidelines Aug 01, 2012 · prodigy study:

Circulation 2012;mar 21:epub ahead of print.

See full list on ahajournals.org From december 2006 to december 2008, a total of 2789 patients underwent screening, and 2013 were ultimately recruited into the study and randomized to receive 1 of the 4 stent types (figure 1). Roughly one fourth of the patient population had a history of diabetes mellitus or prior myocardial infarction. All patients received aspirin (160 to 325 mg orally or 500 mg iv as a loading dose and then 80 to 160 mg orally indefinitely) and clopidogrel (300 or 600 mg orally as a loading dose) and then 75 mg/d for the treatment duration according to the randomization scheme as follows:


Post a Comment for "Prodigy Study Duration Of Dual Antiplatelet Therapy Under Review"